Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_assertion type Assertion NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_head.
- NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_assertion description "[The in vitro antiproliferative activity of gefitinib alone or in combination with hepatocyte growth factor and the cMET antibody DN-30 was assessed in NSCLC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_provenance.
- NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_assertion evidence source_evidence_literature NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_provenance.
- NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_assertion SIO_000772 18467317 NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_provenance.
- NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_assertion wasDerivedFrom befree-2016 NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_provenance.
- NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_assertion wasGeneratedBy ECO_0000203 NP670052.RAaf__g4cI1o9aZLMf4COtx_Jsg5tiQJXYA4l99Af5Wjg130_provenance.